Joint effects of severe obesity and inflammation on mortality in critically ill non−ST−segment elevation myocardial infarction patients: a cohort study with external validation - Scorecard - MDSpire

Joint effects of severe obesity and inflammation on mortality in critically ill non−ST−segment elevation myocardial infarction patients: a cohort study with external validation

  • By

  • Yuqing Li

  • Yuhang Wang

  • Pengju Lu

  • Jiaxin Wang

  • Weiwei Tian

  • Ran Chu

  • Jingxi Chen

  • Lai Jiang

  • Changping Li

  • Yin Liu

  • Jing Gao

  • June 24, 2026

  • 0 min

Share

Clinical Scorecard: Combined Impact of Severe Obesity and Inflammation on Mortality Among Critically Ill Patients with Non−ST−Segment Elevation Myocardial Infarction: A Cohort Analysis with External Validation

At a Glance

CategoryDetail
ConditionNon-ST-segment elevation myocardial infarction (NSTEMI)
Key MechanismsAssociation between body mass index (BMI) and mortality; role of C-reactive protein (CRP) in risk stratification.
Target PopulationCritically ill NSTEMI patients
Care SettingCoronary care unit (CCU)

Key Highlights

  • Severe obesity (BMI ≥ 35 kg/m2) linked to increased in-hospital and 10-year mortality.
  • Overweight and obesity I associated with lower mortality risk compared to normal weight.
  • Elevated CRP (≥ 2 mg/L) combined with severe obesity identifies a high-risk clinical profile.
  • CRP addition to risk models improves prediction metrics.
  • Study validated across three cohorts: TAMI, MIMIC-IV, and eICU-CRD.

Guideline-Based Recommendations

Diagnosis

  • NSTEMI diagnosis based on the Fourth Universal Definition of Myocardial Infarction.

Management

  • Integrated metabolic-inflammatory risk stratification for critically ill NSTEMI patients.

Monitoring & Follow-up

  • Monitor BMI and CRP levels to assess mortality risk.

Risks

  • Severe obesity and elevated CRP are associated with higher mortality risks.

Patient & Prescribing Data

Critically ill patients with NSTEMI admitted to CCU.

Management should consider BMI and inflammatory markers for risk stratification.

Clinical Best Practices

  • Utilize BMI and CRP levels in assessing mortality risk in NSTEMI patients.
  • Implement integrated management strategies addressing both obesity and inflammation.

Related Resources & Content

Original Source(s)

Joint effects of severe obesity and inflammation on mortality in critically ill non−ST−segment elevation myocardial infarction patients: a cohort study with external validation

  • by Yuqing Li, Yuhang Wang, Pengju Lu, Jiaxin Wang, Weiwei Tian, Ran Chu, Jingxi Chen, Lai Jiang, Changping Li, Yin Liu, Jing Gao

  • June 24, 2026

Related Content

Associations of clinical obesity with arterial stiffness and cerebral small vessel disease: a population-based study

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis